US Army lab picks lead Covid-19 vaccine candidate

Coronavirus chronicle

TBS Report
11 June, 2020, 08:20 pm
Last modified: 11 June, 2020, 08:22 pm
The lead vaccine candidate was selected from more than two dozen prototypes
The ultrastructural morphology exhibited by the 2019 Novel Coronavirus, which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, US January 29, 2020/Reuters

The US Army laboratory at the Walter Reed Army Institute of Research has selected a lead Covid-19 vaccine candidate as well as two backup vaccine candidates "that will advance to the next stage of research," the Army announced today.

The lead vaccine candidate was selected from more than two dozen prototypes, reports the CNN. 

"The candidates were narrowed down from more than two dozen prototypes in order to determine the candidates that elicited the most promising antibody response in preclinical studies," the statement said.

US Army is supporting the government's intergovernmental vaccine project known as Operation Warp Speed, which is aimed at accelerating the development, manufacturing, and distribution of Covid-19 vaccines, therapeutics, and diagnostics.

 

 

 

 

Related Topics

Coronavirus Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.